Format

Send to

Choose Destination
See comment in PubMed Commons below
Semin Cutan Med Surg. 2008 Mar;27(1):16-24. doi: 10.1016/j.sder.2007.12.004.

DNA microarray technology in dermatology.

Author information

1
Department of Dermatology and Venereology, University of Rostock, Rostock, Germany. manfred.kunz@med.uni-rostock.de

Abstract

In recent years, DNA microarray technology has been used for the analysis of gene expression patterns in a variety of skin diseases, including malignant melanoma, psoriasis, lupus erythematosus, and systemic sclerosis. Many of the studies described herein confirmed earlier results on individual genes or functional groups of genes. However, a plethora of new candidate genes, gene patterns, and regulatory pathways have been identified. Major progresses were reached by the identification of a prognostic gene pattern in malignant melanoma, an immune signaling cluster in psoriasis, and a so-called interferon signature in systemic lupus erythematosus. In future, interference with genes or regulatory pathways with the use of different RNA interference technologies or targeted therapy may not only underscore the functional significance of microarray data but also may open interesting therapeutic perspectives. Large-scale gene expression analyses may also help to design more individualized treatment approaches of cutaneous diseases.

PMID:
18486020
DOI:
10.1016/j.sder.2007.12.004
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Frontline Medical Communications Inc
    Loading ...
    Support Center